Proteomics Information
How Tuberculosis Might Be Thwarting Immune System: Proteomics Study Yields Clues (Science Daily) A link between the immune system and the self-cleaning system by which biological cells rid themselves of obsolete or toxic parts may one day yield new weapons in the fight against tuberculosis and other deadly infectious diseases. Berkeley Lab researchers have discovered proteins residing in both systems that point to "cross-talk" between them.
Proteomics study yields clues as to how tuberculosis might be thwarting the immune system (PhysOrg) A link between the immune system and the self-cleaning system by which biological cells rid themselves of obsolete or toxic parts may one day yield new weapons in the fight against tuberculosis and other deadly infectious diseases. Scientists with the U.S. Department of Energy's (DOE) Lawrence Berkeley National Laboratory have discovered proteins residing in both systems that point to ...
06.11.2008 - DJ HUGIN NEWS/QIAGEN and Institute for Animal Health Enter Partnership in Bluetongue Testing (4investors) Venlo, The Netherlands - November 6, 2008 - QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) has announced today that it has entered into a worldwide exclusive partnership with the Institute for Animal Health (IAH), a leading research and diagnostics institution for infectious diseases of farm animals.
Clues As To How Tuberculosis Might Be Thwarting The Immune System (Medical News Today) A link between the immune system and the self-cleaning system by which biological cells rid themselves of obsolete or toxic parts may one day yield new weapons in the fight against tuberculosis and other deadly infectious diseases. Scientists with the U.S.
Through The Eye Of A Needle - Labcyte Awarded U. S. Patent Describing The Acoustic Transfer Of Droplets Into Small ... (PharmaceuticalOnline) Labcyte Inc., the pioneer in 'touchless' acoustic transfer of liquids, announces the issuance of U.S. Patent 7,405,395 which exploits the unique advantages of using sound to move liquids.
News From BioScience, November 2008 (Medical News Today) The complete list of research articles in the November 2008 issue of BioScience is as follows: Identifying and Characterizing Bacteria in an Era of Genomics and Proteomics David Emerson, Liane Agulto, Henry Liu, and Liping Liu. New molecular technologies in genomics and proteomics are changing techniques used for identifying bacteria.
Invitrogen Launches Microarray to Study Non-Coding RNA (Centre Daily Times) Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the launch of the first high-density microarray for the profiling of non-coding RNAs. The NCode(TM) Human and Mouse non-coding RNA microarrays consist of both non-coding RNA and messenger RNA (mRNA) content on the same array. The arrays are designed by ...
Proteomics provides clues to how tuberculosis thwarts the immune system (News-Medical-Net) A link between the immune system and the self-cleaning system by which biological cells rid themselves of obsolete or toxic parts may one day yield new weapons in the fight against tuberculosis and other deadly infectious diseases.
Proteomics study yields clues as to how tuberculosis might be thwarting the immune system (EurekAlert!) ( DOE/Lawrence Berkeley National Laboratory ) A link between the immune system and the self-cleaning system by which biological cells rid themselves of obsolete or toxic parts may one day yield new weapons in the fight against tuberculosis and other deadly infectious diseases. Berkeley Lab researchers have discovered proteins residing in both systems that point to "cross-talk" between them.
Breast Cancer - Targeting A Protein Called Cyclin D1 May Block The Expansion Of Cancerous Stem Cells (Medical News Today) Breast cancer stem cells are known to be involved in therapy resistance and the recurrence of cancerous tumors. A new study appearing in Clinical and Translational science shows the mechanisms governing stem cell expansion in breast cancer (called Notch activity), and finds that therapy targeting a protein called cyclin D1 may block the expansion of cancerous stem cells.
|